Age-related macular degeneration(AMD)was a main cause leading to low vision and blindness of theWestern countries elderly population. AMD has become a hotspot in the ophthalmology research. According to the clinical and pathological finding, it was divided to the dry and wet two types, and the dry type was accounting for about 90 percent. So the aim of the article was to analyze and summarize the pathophysiological mechanisms and recent drug treatment methods to the dry AMD, so as to provide evidence for the future treatment of AMD.